Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 13 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 30 most recent Form 4 transactions.
| $5.3K |
| <0.1% |
| Open the original filing on SEC.gov |
| Sep 15 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 759 | $79.00 | $60K | -0.8% | Open the original filing on SEC.gov |
| Sep 15 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 11,675 | $78.33 | $914.5K | -10.9% | Open the original filing on SEC.gov |
| Sep 15 | TARS | Tarsus Pharmaceuticals,… | MEXER◷ | 201 | — | — | +0.2% | Open the original filing on SEC.gov |
| Jun 25 | TARS | Tarsus Pharmaceuticals,… | AGRANT◆ | 806 | — | — | — | Open the original filing on SEC.gov |
| Jun 25 | TARS | Tarsus Pharmaceuticals,… | AGRANT◆ | 2,417 | — | — | — | Open the original filing on SEC.gov |
| Jun 25 | TARS | Tarsus Pharmaceuticals,… | AGRANT◆ | 3,837 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | RXST | RxSight, Inc. | AGRANT | 37,037 | — | — | +97.8% | Open the original filing on SEC.gov |
| Jun 15 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 1,928 | $62.94 | $121.3K | -1.8% | Open the original filing on SEC.gov |
| Jun 15 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 10,572 | $61.97 | $655.1K | -8.9% | Open the original filing on SEC.gov |
| Jun 12 | TARS | Tarsus Pharmaceuticals,… | MEXER◆ | 2,954 | — | — | — | Open the original filing on SEC.gov |
| Jun 12 | TARS | Tarsus Pharmaceuticals,… | MEXER | 2,954 | — | — | +2.5% | Open the original filing on SEC.gov |
| Jun 3 | LNSR | LENSAR, Inc. | AGRANT | 17,421 | — | — | +3.2% | Open the original filing on SEC.gov |
| Mar 16 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 493 | $69.75 | $34.4K | -0.4% | Open the original filing on SEC.gov |
| Mar 16 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 8,378 | $69.03 | $578.3K | -6.7% | Open the original filing on SEC.gov |
| Mar 16 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 3,629 | $68.09 | $247.1K | -2.8% | Open the original filing on SEC.gov |
| Dec 15, 2025 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 4,766 | $81.50 | $388.4K | -100.0% | Open the original filing on SEC.gov |
| Dec 15, 2025 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 5,680 | $80.71 | $458.4K | -54.4% | Open the original filing on SEC.gov |
| Dec 15, 2025 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 1,148 | $82.39 | $94.6K | -0.9% | Open the original filing on SEC.gov |
| Dec 15, 2025 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 6,306 | $81.75 | $515.5K | -4.6% | Open the original filing on SEC.gov |
| Dec 15, 2025 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 5,046 | $80.80 | $407.7K | -3.6% | Open the original filing on SEC.gov |
| Sep 16, 2025 | TARS | Tarsus Pharmaceuticals,… | GGIFT | 2,000 | — | — | -1.4% | Open the original filing on SEC.gov |
| Sep 8, 2025 | TARS | Tarsus Pharmaceuticals,… | SSELL | 27,116 | $57.00 | $1.5M | -15.9% | Open the original filing on SEC.gov |
| Jun 13, 2025 | TARS | Tarsus Pharmaceuticals,… | MEXER◆ | 3,350 | — | — | — | Open the original filing on SEC.gov |
| Jun 13, 2025 | TARS | Tarsus Pharmaceuticals,… | MEXER | 3,350 | — | — | +2.0% | Open the original filing on SEC.gov |
| Jun 12, 2025 | TARS | Tarsus Pharmaceuticals,… | AGRANT◆ | 2,954 | — | — | — | Open the original filing on SEC.gov |
| Jun 12, 2025 | TARS | Tarsus Pharmaceuticals,… | AGRANT◆ | 4,540 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | RXST | RxSight, Inc. | AGRANT | 10,752 | — | — | +39.7% | Open the original filing on SEC.gov |
| May 23, 2025 | LNSR | LENSAR, Inc. | AGRANT | 7,374 | — | — | +1.4% | Open the original filing on SEC.gov |